Purchases and Sales Made in Q2 2024 in Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT) during Q2 2024. The information is specifically focused on institutions that hold shares of Arcutis Biotherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-380K- 40.31% |
$2.75M - $4.77M
|
563K
$7.95M
|
|
|
Aug 14, 2024
Q2 2024
|
Sio Capital Management, LLC
New York, NY |
SELL
|
- |
-476K- 74.9% |
$3.45M - $5.97M
|
160K
$2.25M
|
|
|
Aug 12, 2024
Q2 2024
|
Hsbc Holdings PLC
London, X0 |
SELL
|
- |
-492K- 97.22% |
$3.56M - $6.17M
|
14.1K
$199K
|
|
|
Aug 13, 2024
Q2 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-563K- 68.45% |
$4.08M - $7.05M
|
259K
$3.66M
|
|
|
Aug 05, 2024
Q2 2024
|
Jennison Associates LLC
|
SELL
|
- |
-605K- 4.97% |
$4.38M - $7.58M
|
11.6M
$163M
|
|
|
Aug 14, 2024
Q2 2024
|
Gilder Gagnon Howe & CO LLC
New York, NY |
SELL
|
- |
-618K- 14.6% |
$4.48M - $7.75M
|
3.62M
$51M
|
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-662K- 92.38% |
$4.79M - $8.29M
|
54.6K
$770K
|
|
|
Aug 13, 2024
Q2 2024
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-847K- 28.41% |
$6.13M - $10.6M
|
2.13M
$30.1M
|
|
|
Aug 12, 2024
Q2 2024
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
SELL
|
- |
-981K- 48.76% |
$7.1M - $12.3M
|
1.03M
$14.5M
|
|
|
Aug 13, 2024
Q2 2024
|
Stem Point Capital LP
New York, NY |
SELL
|
- |
-1.24M- 56.24% |
$8.98M - $15.5M
|
965K
$13.6M
|
|
|
Aug 14, 2024
Q2 2024
|
Farallon Capital Management LLC
San Francisco, CA |
SELL
|
- |
-1.75M- 98.54% |
$12.7M - $22M
|
26K
$367K
|
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-3.65M- 41.54% |
$26.4M - $45.7M
|
5.13M
$72.5M
|